These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 12019166)
41. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines. Chen PW; Ksander BR Curr Eye Res; 2006 Jan; 31(1):43-55. PubMed ID: 16421019 [TBL] [Abstract][Full Text] [Related]
42. Vaccine therapy of established tumors in the absence of autoimmunity. Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742 [TBL] [Abstract][Full Text] [Related]
43. Different antitumor immunity roles of cytokine activated T lymphocytes from naive murine splenocytes and from dendritic cells-based vaccine primed splenocytes: implications for adoptive immunotherapy. Zhang S; Wang Q; Li WF; Wang HY; Zhang HJ; Zhu JJ Eksp Onkol; 2004 Mar; 26(1):55-62. PubMed ID: 15112581 [TBL] [Abstract][Full Text] [Related]
44. Retroviral-mediated IL-12 gene transduction into human CD34+ cell-derived dendritic cells. Akiyama Y; Maruyama K; Watanabe M; Yamaguchi K Int J Oncol; 2002 Sep; 21(3):509-14. PubMed ID: 12168093 [TBL] [Abstract][Full Text] [Related]
45. Human immune response towards recombinant Helicobacter pylori urease and cellular fractions. Voland P; Zeitner M; Hafsi N; Prinz C Vaccine; 2006 May; 24(18):3832-9. PubMed ID: 16122847 [TBL] [Abstract][Full Text] [Related]
46. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267 [TBL] [Abstract][Full Text] [Related]
47. [Preparation of renal cancer vaccine of IL-12-anchored exosomes and its antitumor effect in vitro]. Zhang Y; Wu XH; Chen G; Luo CL; Zhang JM Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):339-43. PubMed ID: 20723430 [TBL] [Abstract][Full Text] [Related]
48. Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules. Cimino AM; Palaniswami P; Kim AC; Selvaraj P Immunol Res; 2004; 29(1-3):231-40. PubMed ID: 15181285 [TBL] [Abstract][Full Text] [Related]
49. Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells. De Nardo C; Fonsatti E; Sigalotti L; CalabrĂ² L; Colizzi F; Cortini E; Coral S; Altomonte M; Maio M J Cell Physiol; 2002 Feb; 190(2):200-6. PubMed ID: 11807824 [TBL] [Abstract][Full Text] [Related]
50. Enhanced response of T lymphocytes from Pgap3 knockout mouse: Insight into roles of fatty acid remodeling of GPI anchored proteins. Murakami H; Wang Y; Hasuwa H; Maeda Y; Kinoshita T; Murakami Y Biochem Biophys Res Commun; 2012 Jan; 417(4):1235-41. PubMed ID: 22227195 [TBL] [Abstract][Full Text] [Related]
51. [Antitumor effect of GPI-CD80 fusion protein in nude mice]. Liu Y; Liu SJ; Zhang X; Lin JM Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1027-9. PubMed ID: 17666344 [TBL] [Abstract][Full Text] [Related]
52. A glycophospholipid anchor is required for Qa-2-mediated T cell activation. Robinson PJ; Millrain M; Antoniou J; Simpson E; Mellor AL Nature; 1989 Nov; 342(6245):85-7. PubMed ID: 2530453 [TBL] [Abstract][Full Text] [Related]
53. The glycosylphosphatidylinositol-anchored form and the transmembrane form of CD58 associate with protein kinases. Itzhaky D; Raz N; Hollander N J Immunol; 1998 May; 160(9):4361-6. PubMed ID: 9574540 [TBL] [Abstract][Full Text] [Related]
54. Cellular expression of a GPI-linked T cell activation protein. Haregewoin A; Solomon K; Hom RC; Soman G; Bergelson JM; Bhan AK; Finberg RW Cell Immunol; 1994 Jul; 156(2):357-70. PubMed ID: 8025953 [TBL] [Abstract][Full Text] [Related]
55. [Anchoring cytokines to cancer cells using diphtheria toxin: better than immunotherapy by gene transfer?]. Nizard P; Gross DA; Chenal A; Beaumelle B; Kosmatopoulos K; Gillet D J Soc Biol; 2001; 195(3):229-34. PubMed ID: 11833459 [TBL] [Abstract][Full Text] [Related]
56. Construction, expression and functional analysis of a glycolipid-linked form of CR1. Clissold PM; Ebling HJ; Lachmann PJ Eur J Immunol; 1993 Sep; 23(9):2346-52. PubMed ID: 8370411 [TBL] [Abstract][Full Text] [Related]
57. Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis. Wang X; He X; Zhao F; Wang J; Zhang H; Shi F; Zhang Y; Cai K; Dou J J Transl Med; 2014 Mar; 12():68. PubMed ID: 24625224 [TBL] [Abstract][Full Text] [Related]
58. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). McHugh RS; Ahmed SN; Wang YC; Sell KW; Selvaraj P Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8059-63. PubMed ID: 7544014 [TBL] [Abstract][Full Text] [Related]
59. LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors. Abina MA; Lee MG; Descamps V; Cordier L; Lopez M; Perricaudet M; Haddada H Gene Ther; 1996 Mar; 3(3):212-6. PubMed ID: 8646551 [TBL] [Abstract][Full Text] [Related]
60. Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development. van Broekhoven CL; Parish CR; Vassiliou G; Altin JG J Immunol; 2000 Mar; 164(5):2433-43. PubMed ID: 10679080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]